Abstract Number: 1171 • ACR/ARHP Annual Meeting 2015
Plasma Soluble ST2 Levels Are Independently Associated with Both Carotid Atherosclerosis and Compromised Cortical Volumetric Bone Mineral Density and Microstructure in Patients with Psoriatic Arthritis
Background/Purpose: Patients with PsA have both increased risk of subclinical atherosclerosis and lower cortical volumetric BMD (vBMD) compared with the general population, probably as a…Abstract Number: 1702 • ACR/ARHP Annual Meeting 2015
Osteoporosis in Psoriatic Arthritis
Background/Purpose: Psoriatic Arthritis (PsA) is an inflammatory arthritis affecting peripheral and axial joints in patients with psoriasis. The disease process in PsA comprises of complex…Abstract Number: 1709 • ACR/ARHP Annual Meeting 2015
Subclinical Atherosclerosis in Patients with Psoriatic Arthritis and the Role of Vitamin D
Background/Purpose: Psoriatic arthritis (PsA) is associated with increased cardiovascular risk (CV)[i]. Several studies associate low levels of 25-hydroxivitamin D (25OHD) with a greater prevalence of…Abstract Number: 1560 • ACR/ARHP Annual Meeting 2014
Rheumatoid Factor Status Is a Predictor of Osteoporosis in Patients with Psoriatic Arthritis
Background/Purpose Osteoporosis is an important comorbidity in patients with rheumatic diseases, but risk factors for osteoporosis in Psoriatic Arthritis (PsA) patients have not been explored. …
